PHK
ALLO icon

Point72 Hong Kong’s Allogene Therapeutics ALLO Stock Holding History

Point72 Hong Kong’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,467
Closed -$104K – 1877
2022
Q1 		$104K Buy
11,467
+7,237
+171% +$75.4K ﹤0.01% 1146
2021
Q4 		$63K Buy
+4,230
New +$74.6K ﹤0.01% 1282
2021
Q1 		– Sell
-1,066
Closed -$27K – 1769
2020
Q4 		$27K Buy
+1,066
New +$34.7K ﹤0.01% 1359
2020
Q3 		– Sell
-162
Closed -$7K – 1165
2020
Q2 		$7K Buy
+162
New +$5.86K ﹤0.01% 1011

Other funds holding ALLO

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Hong Kong's ALLO Position: Q2 2022 in Review

Point72 Hong Kong sold out of Allogene Therapeutics (ALLO) in Q2 2022, closing a stake of 11,467 shares — an estimated $104K sold.

Point72 Hong Kong first reported a position in ALLO in Q2 2020 and held it in 4 quarters. The position peaked at $104K in Q1 2022. 161 funds tracked by Wall St. Rank hold ALLO as of Q2 2022.

  • Point72 Hong Kong reported no remaining Allogene Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 11,467 Allogene Therapeutics shares in Q2 2022, an estimated $104K.
  • Point72 Hong Kong first reported a position in Allogene Therapeutics in Q2 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Allogene Therapeutics position peaked at $104K in Q1 2022.
  • 161 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.